PHP
CVS icon

Parkman Healthcare Partners’s CVS Health CVS Stock Holding History

Parkman Healthcare Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5M Buy
391,791
+4,485
+1% +$400K 4.15% 3
2026
Q1 		$27.8M Sell
387,306
-62,906
-14% -$4.85M 2.87% 9
2025
Q4 		$35.7M Buy
450,212
+70,726
+19% +$5.58M 3.4% 5
2025
Q3 		$28.6M Sell
379,486
-138,321
-27% -$9.48M 2.98% 5
2025
Q2 		$35.7M Buy
517,807
+21,071
+4% +$1.38M 4.11% 1
2025
Q1 		$33.7M Buy
496,736
+316,736
+176% +$19M 3.99% 2
2024
Q4 		$8.08M Buy
+180,000
New +$10.1M 1.08% 35
2022
Q4 		– Sell
-117,634
Closed -$11.2M – 86
2022
Q3 		$11.2M Buy
117,634
+64,087
+120% +$6.34M 3.19% 7
2022
Q2 		$4.96M Sell
53,547
-32,071
-37% -$3.13M 1.83% 18
2022
Q1 		$8.66M Sell
85,618
-47,716
-36% -$5.01M 2.54% 14
2021
Q4 		$13.8M Buy
+133,334
New +$12.3M 3.04% 8

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Parkman Healthcare Partners's CVS Position: Q2 2026 in Review

Parkman Healthcare Partners increased its CVS Health (CVS) stake by 1.2% in Q2 2026, buying an estimated $400K and bringing the position to 391,791 shares worth $40.5M. The position accounts for 4.15% of the portfolio, ranked #3.

Parkman Healthcare Partners first reported a position in CVS in Q4 2021 and has held it in 11 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Parkman Healthcare Partners held 391,791 shares of CVS Health worth $40.5M as of Q2 2026.
  • Parkman Healthcare Partners bought 4,485 CVS Health shares in Q2 2026, an estimated $400K.
  • CVS Health made up 4.15% of Parkman Healthcare Partners's portfolio in Q2 2026, its #3 holding.
  • Parkman Healthcare Partners first reported a position in CVS Health in Q4 2021 and has held it in 11 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.